Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Paul Steven M
Relationship:  
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   1,185,025    

Indirect Shares

   632,151      
Direct Value   $37,673,864    

Indirect Value

   $30,104,525      
Total Shares   1,817,176      
Total Value   $67,778,389      


Eli Lilly & Co $29,994,255 Sage Therapeutics, Inc. $0 Alnylam Pharmaceuticals Inc $151,220 Voyager Therapeutics, Inc. $7,528,389 Eli Lilly & Co $29,994,255 Sage Therapeutics, Inc. $0 Alnylam Pharmaceuticals Inc $151,220 Voyager Therapeutics, Inc. $7,528,389
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Eli Lilly & Co LLY EVP, Science and Techn... 2010-02-01 38,897 2010-02-01 39,040    Premium*  
            Sigma-Aldrich Corp SIAL Director 2015-11-18 0 2007-01-02 0    Premium*  
            Sage Therapeutics, Inc. SAGE 2019-03-21 272,777 2022-11-28 593,111    Premium*  
            Alnylam Pharmaceuticals Inc ALNY Director 2022-04-01 1,000 2015-01-26 0    Premium*  
            Voyager Therapeutics, Inc. VYGR President and CEO, Dir... 2016-01-14 872,351 0    Premium*  
            Karuna Therapeutics, Inc. KRTX 2024-03-18 0 2024-03-18 0    Premium*  
* Premium Members only  

Records found :    131         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SAGE Sage Therapeutics, Inc.   –       •      –    2019-02-25 4 AS $161.00 $322,000 I/I (2,000) 70,900 0 -
SAGE Sage Therapeutics, Inc.   –       •      –    2019-03-01 4 AS $161.00 $418,600 I/I (2,600) 190,700 0 -
SAGE Sage Therapeutics, Inc.   –       •      –    2019-03-18 4 AS $161.01 $607,977 I/I (3,775) 186,925 0 -
SAGE Sage Therapeutics, Inc.   –       •      –    2019-03-20 4 AS $161.20 $9,136,582 I/I (56,646) 130,279 0 -
SAGE Sage Therapeutics, Inc.   –       •      –    2019-03-21 4 AS $161.02 $1,268,824 I/I (7,879) 122,400 0 -
KRTX Karuna Therapeutics, Inc. President & CEO   •       •      –    2019-06-28 4 B $22.86 $230,424 D/D 10,000 10,000 2.81 -
KRTX Karuna Therapeutics, Inc. President & CEO   •       •      –    2019-07-02 4 A $0.00 $0 D/D 96,485 106,485 0 -
ALNY Alnylam Pharmaceuticals I... Director   –       •      –    2020-02-10 4 AS $130.00 $3,900,000 D/D (30,000) 1,000 0 %
ALNY Alnylam Pharmaceuticals I... Director   –       •      –    2020-02-10 4 OE $14.67 $440,100 D/D 30,000 31,000 0 -
ALNY Alnylam Pharmaceuticals I... Director   –       •      –    2020-12-18 4 OE $9.30 $139,500 D/D 15,000 16,000 0 -
ALNY Alnylam Pharmaceuticals I... Director   –       •      –    2020-12-18 4 AS $140.00 $2,100,000 D/D (15,000) 1,000 0 %
KRTX Karuna Therapeutics, Inc. PRESIDENT & CEO   •       •      –    2021-08-17 4 B $105.63 $124,960 I/I 1,183 107,668 0.01 -
KRTX Karuna Therapeutics, Inc. PRESIDENT & CEO   •       •      –    2021-08-18 4 B $106.10 $125,304 I/I 1,181 108,849 0.01 -
SAGE Sage Therapeutics, Inc.   –       •      –    2021-11-09 4 A $43.36 $43 I/I 1 1 0 -
ALNY Alnylam Pharmaceuticals I... Director   –       •      –    2022-04-01 4 AS $166.04 $2,560,371 D/D (15,000) 1,000 0 %
ALNY Alnylam Pharmaceuticals I... Director   –       •      –    2022-04-01 4 OE $11.33 $169,950 D/D 15,000 16,000 0 -
KRTX Karuna Therapeutics, Inc. CSO and President of R&D   •       •      –    2022-05-27 4 GD $0.00 $0 I/I 106,485 0 0 -
KRTX Karuna Therapeutics, Inc. CSO and President of R&D   •       •      –    2022-05-27 4 GA $0.00 $0 I/I 106,485 106,485 0 -
KRTX Karuna Therapeutics, Inc. CSO and President of R&D   •       •      –    2022-05-31 4 GD $0.00 $0 I/I 106,485 0 0 -
KRTX Karuna Therapeutics, Inc. CSO and President of R&D   •       •      –    2022-05-31 4 GA $0.00 $0 I/I 106,485 106,485 0 -
SAGE Sage Therapeutics, Inc.   –       •      –    2022-11-28 4 A $38.17 $191 I/I 5 78,539 0 -
KRTX Karuna Therapeutics, Inc. CSO and President of R&D   •       •      –    2023-02-09 4 A $0.00 $0 D/D 11,400 11,400 0 -
KRTX Karuna Therapeutics, Inc.   –       •      –    2024-02-09 4 D $317.14 $254,981 D/D (804) 10,596 0 -
KRTX Karuna Therapeutics, Inc.   –       •      –    2024-02-23 4 OE $7.27 $599,675 D/D 31,518 42,114 0 -
KRTX Karuna Therapeutics, Inc.   –       •      –    2024-02-29 4 A $315.18 $14,932,598 I/I 47,378 70,608 0 -
  131  Records found
  1   2   3   4   5  6      
  Page 5 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us